Savient Pharmaceuticals Files For Ch. 11, Plans $55M Sale
Cash-strapped drug developer Savient Pharmaceuticals Inc. filed for Chapter 11 in Delaware bankruptcy court on Monday, seeking to sell its assets to a unit of US WorldMeds LLC, which has signed...To view the full article, register now.
Already a subscriber? Click here to view full article